| 000 | 01649 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517112318.0 | ||
| 264 | 0 | _c20170424 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1097-6787 | ||
| 024 | 7 |
_a10.1016/j.jaad.2016.03.050 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Yu-Tsung | |
| 245 | 0 | 0 |
_aEarly application of low-level laser may reduce the incidence of postherpetic neuralgia (PHN). _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cSep 2016 |
||
| 300 |
_a572-577 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_a2-Aminopurine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFamciclovir |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHerpes Zoster _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 |
_aLow-Level Light Therapy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeuralgia, Postherpetic _xprevention & control |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWang, Hsiao-Han | |
| 700 | 1 | _aWang, Tsung-Jen | |
| 700 | 1 | _aLi, Yu-Chuan | |
| 700 | 1 | _aChen, Ting-Jui | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 75 _gno. 3 _gp. 572-577 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaad.2016.03.050 _zAvailable from publisher's website |
| 999 |
_c26344573 _d26344573 |
||